Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 28;29(24):3843-3854.
doi: 10.3748/wjg.v29.i24.3843.

Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B

Yewan Park  1   2 , Danbee Kang  3   4 , Dong Hyun Sinn  2   5 , Hyunsoo Kim  6 , Yun Soo Hong  7 , Juhee Cho  3   6   7 , Geum-Youn Gwak  5
Affiliations

Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B

Yewan Park et al. World J Gastroenterol. .

Abstract

Background: Research exploring the influence of healthier lifestyle modification (LSM) on the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) is limited.

Aim: To emulate a target trial to determine the effect of LSM on HCC incidence and mortality among patients with CHB by large-scale population-based observational data.

Methods: Among the patients with CHB enrolled in the Korean National Health Insurance Service between January 1, 2009, and December 31, 2017, those aged ≥ 20 years who drank alcohol, smoked cigarettes, and were sedentary were analyzed. Exposure included at least one LSM, including alcohol abstinence, smoking cessation, and regular exercise. The primary outcome was HCC development, and the secondary outcome was liver-related mortality. We used 2:1 propensity score matching to account for covariates.

Results: With 48766 patients in the LSM group and 103560 in the control group, the adjusted hazard ratio (HR) for incident HCC and liver-related mortality was 0.92 [95% confidence interval (CI): 0.87-0.96] and 0.92 (95%CI: 0.86-0.99) in the LSM group, respectively, compared with the control group. Among the LSM group, the adjusted HR (95%CI) for incident HCC was 0.84 (0.76-0.94), 0.87 (0.81-0.94), and 1.08 (1.00-1.16) for alcohol abstinence, smoking cessation, and regular exercise, respectively. The adjusted HR (95%CI) for liver-related mortality was 0.92 (0.80-1.06), 0.81 (0.72-0.91), and 1.15 (1.04-1.27) for alcohol abstinence, smoking cessation, and regular exercise, respectively.

Conclusion: LSM lowered the risk of HCC and mortality in patients with CHB. Thus, active LSM, particularly alcohol abstinence and smoking cessation, should be encouraged in patients with CHB.

Keywords: Cancer; Chronic hepatitis B; Hepatocellular carcinoma; Lifestyle modification; Mortality.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: All authors have nothing to disclose.

Figures

Figure 1
Figure 1
Flow chart of study participants. HBV: Hepatitis B virus; HIV: Human immunodeficiency virus; HCV: Hepatitis C virus.
Figure 2
Figure 2
Covariate balance check. AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; CCT: γ-glutamyl transferase; BMI: Body mass index.
See this image and copyright information in PMC

References

    1. Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, McGlynn KA, Soerjomataram I. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77:1598–1606. - PMC - PubMed
    1. Maucort-Boulch D, de Martel C, Franceschi S, Plummer M. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide. Int J Cancer. 2018;142:2471–2477. - PubMed
    1. Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines for management of chronic hepatitis B. Clin Mol Hepatol. 2019;25:93–159. - PMC - PubMed
    1. Jachs M, Tillmann HL. It's not all about the virus-On the importance of modifiable lifestyle factors in the development of hepatocellular carcinoma in chronic hepatitis B. Hepatology. 2023;77:352–354. - PubMed
    1. Wu S, Zhou J, Wu X, Sun Y, Wang B, Kong Y, Zhan S, Jia J, Yang HI, You H. Comparative Performance of 14 HCC Prediction Models in CHB: A Dynamic Validation at Serial On-Treatment Timepoints. Am J Gastroenterol. 2022;117:1444–1453. - PubMed

MeSH terms

Substances